PMCB vs POOL · $8.6M cap vs P/E 18, rev $5.31B
PharmaCyte Biotech Inc (PMCB) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
PMCB currently screens at market cap $8.6M. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the PMCB and POOL stock pages for the full models.
Not investment advice.